CS Paper Radar

Retrieval-Augmented Vision Foundation Models for Robust Leukemia Cell Classification across Multiple Microscopy Datasets

Carlos Zamora, Hiram Zuniga, Ulises Orozco-Rosas, Kenia Picos

eess.IV cs.CVcs.LG ·submitted 2026-08-11 08:39 UTC · v1
published

Abstract

Leukemia cell image classification is challenged by real-world domain shifts from acquisition, staining, illumination, and site protocols, causing single-dataset models to generalize poorly in real clinical scenarios. This work presents a robust framework for leukemia classification across multiple heterogeneous datasets using a two-stage pipeline with a pretrained vision foundation model. Stage 1 performs binary classification (leukemia vs. non-leukemia) and is trained using 122,167 single-cell images. Stage 2 is conditionally applied to Stage 1 positives to perform subtype classification into Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML), trained using 69,400 single-cell images. Labels are harmonized across five heterogeneous datasets to enable cross-dataset training, and performance is evaluated on a held-out dataset protocol to assess domain-shift generalization. Within this pipeline, three encoders are benchmarked (DinoBloom, pretrained on single-cell images; BiomedCLIP, pretrained on biomedical data; and CLIP as a general-purpose model) under linear probing, Low-Rank Adaptation (LoRA), and a Retrieval-Augmented Classification (RAC) module that retrieves the top-k most similar cell images to provide cytomorphological grounding. The objective is to quantify how much domain-specific pretraining contributes to performance under domain shift, and whether cost-effective adaptation and retrieval can be a viable alternative to expensive domain-specialized pretraining. The held-out protocol additionally serves as a diagnostic tool, revealing when classification performance is attributable to dataset-specific artifacts rather than to cytomorphological features.

Comment
Accepted at SPIE Optics + Photonics 2026 for oral presentation. 23 pages, 12 figures, 9 tables

Closest papers

Nearest neighbours by meaning across the whole index.

HERO: Histology Encoder for Robust Representation in Oncology

cs.CV ·2026-09-28 ·Zhi Li, Eghbal Amidi, Yating Cheng, Tyson Dawson, Gorkem Can Ates +9 more
benchmarkcode/data similarity 0.71
Abstract · 22 pages, 4 figures, 13 tables; author information updated; scientific content unchanged

Foundation models trained on large pathology image corpora now provide strong, transferable representations for computational pathology. Over the past few years a series of such models has been released, each trained on more slides than the last; on standard classification and segmentation benchmarks, the leading models are now separated by small margins. In clinical use, however, the foundation model is applied to images from hospitals, scanners, and staining protocols outside its training data. Encoders generally embed these acquisition factors alongside biological information, which may introduce downstream errors and hinder safe clinical adoption. A pathology foundation model should therefore be robust to acquisition shift without giving up representation quality, yet robustness is seldom the axis along which models are compared. In this report, we introduce HERO (Histology Encoder for Robust Representation in Oncology), a ViT-G/14 pathology foundation model trained with the DINO and iBOT objectives and refined with high-resolution Gram anchoring on a morphology-balanced corpus of 500 million tiles from approximately 575,000 clinical whole-slide images. Across the evaluated public benchmarks, HERO shows the strongest robustness to center, scanner, and stain variation among the compared state-of-the-art foundation models, performs comparably on tile-level classification, segmentation, and gene-expression prediction, ranks first on average across 39 evaluated slide-level clinical tasks, and, under an equal-weighted framework-level analysis, has the best average rank across the six benchmark frameworks.

0.22

MiTHras: Task-specific Hierarchical Semi-supervised Contrastive Masked Autoencoder for Mitotic Figure Analysis

cs.CV cs.LG ·2026-09-21 ·Trinh T. L. Vuong, Simon Graham, Quoc Dang Vu, Phat T. H. Ho, Jeewoo Lim +3 more
published similarity 0.68
Abstract · 15 pages, 4 figures, 9 tables. Includes supplementary material

Mitotic figure (MF) analysis supports tumor grading and prognostic assessment, but automated models remain sensitive to differences in tissue type and image acquisition. We present MiTHras, a task-specific pretraining framework that combines pseudo-label-guided image- and token-level contrastive learning with masked reconstruction. We construct TCGA-MF-Pseudo, a corpus of 1.8 million cell-centered images from 14 TCGA cohorts spanning 11 organ sites. Comprehensive evaluation on MF classification, detection, count-based survival prediction, and subtype classification demonstrates the efficacy of MiTHras. It achieves the highest mean F1 on all three MF classification benchmarks and both subtype benchmarks. MiTHras also outperforms general-purpose and pathology foundation encoders by a larger margin under frozen-encoder linear probing than under full fine-tuning. Although detection gains are modest due to a shared candidate-detection stage, ablations confirm that token-level supervision improves typical-versus-atypical classification and linear probing. These findings establish that MiTHras yields robust, transferable representations for automated mitotic activity assessment.

0.43

Fisher Contrastive Learning to Mitigate Feature Suppression: A Case Study in Acute Promyelocytic Leukemia Diagnosis

cs.LG stat.ML ·2026-10-29 ·Shushan Wu, Yongkai Chen, Xilin Gong, Yufang Liu, Wenxuan Zhong +1 more
theory similarity 0.67
Abstract · 31 pages, including supplementary material; 3 figures and 2 tables

Self-supervised contrastive learning (SSCL) learns representations by contrasting augmented views of the same sample, but it can exhibit feature suppression, where dominant or easy-to-learn factors suppress other class-relevant signals, degrading the performance of representations, particularly in high-dimensional data with heterogeneous features. We introduce Fisher Contrastive Learning (FCL), which uses a regularized Fisher trace criterion to address feature suppression. FCL learns embeddings by maximizing the discriminative strength of Fisher discriminant functions, producing representations that preserve class-relevant information implied by the augmentation process. We prove that the representations learned by FCL could alleviate the feature suppression effects. We demonstrate FCL on simulated benchmarks designed to induce feature suppression and on a real-world biomedical application, pretraining on large white blood cell microscopy image dataset and transfer learning for diagnosis of acute promyelocytic leukemia in an external cohort. In all experiments, FCL outperforms the self-supervised baselines and yields more robust and discriminative representations.

0.26

Multi-scale Fusion of Fast Vision Mamba and Foundation Model Features for Patch-Level Gleason Grading in Computational Pathology

cs.CV ·2026-10-19 ·Zihe Zhang, Weimiao Yu, Piumi Don Simonge
published similarity 0.66
Abstract · 13 pages, 4 figures and 4 tables (including supplementary), Accepted to COMPAYL workshop MICCAI 2026, Comments are welcome!

Automated Gleason grading of prostate whole slide images (WSIs) enables faster and more consistent cancer risk stratification. However, it remains a challenging task due to the subtle morphological differences between grades, the severe class imbalance arising from rare patterns, and the diagnostic features that span multiple spatial scales. Pathology foundation models (FMs) extract strong patch representations but often operate at a single-scale, which limits spatial context and disproportionately affects classes that depend on broader context. The challenge of fusing multiple scales and complementary models, with minimal data and computational resources, remains unresolved. We propose a multi-scale classifier built on state-space models. Our method combines two complementary feature sources: a frozen foundation model, and a lightweight FastVim, pre-trained on ImageNet and distilled from the foundation model, that reads the raw image crops. At each scale, a Mamba model encodes the features from both sources with linear-time spatial context, and a jointly trained head fuses the encoded representations into one prediction. On the PANDA dataset, our method reaches macro F1 of 0.894 and Gleason 5 F1 of 0.802 under 5-fold cross-validation, a 12% and 21% relative improvement over the best single-scale model. A controlled study over 5 foundation models, 5 base classifiers and 3 scales confirms that the gain holds across encoders, with larger improvements observed at smaller scales.

0.30

IFC-SSL-Bench: Benchmarking Self-Supervised Learning for Annotation-Efficient Multispectral Imaging Flow Cytometry

cs.CV ·2026-10-22 ·Angelo Jovin Yamachui Sitcheu, Roxana-Teodora Fetescu, Thomas Lautenschlager, Nils Friederich, Linus Schilpp +4 more
benchmark similarity 0.66
Abstract · 35 pages, six main figures, seven supplementary figures, five tables and four supplemntary tables

Imaging Flow Cytometry (IFC) generates large multispectral datasets, yet the need for expert annotations bottlenecks the development of supervised deep learning models. While Self-Supervised Learning (SSL) offers a solution, its application to IFC remains fragmented and lacks systematic benchmarking. To address this, we present IFC-SSL-Bench, a modular framework for evaluating SSL in IFC. We benchmark six SSL approaches across four backbones on two heterogeneous datasets. By assessing downstream classification performance across annotation regimes of the training sets (1%-100%), we quantify annotation efficiency and identify optimal configurations for high-dimensional biological imaging. SSL matches the performance of fully supervised baselines trained on 100% of annotated data while using as little as 5% of annotations for morphological classification, with advantages in low-data regimes below 5%. Across both datasets, the contrastive approach MoCo-v2 paired with ConvNeXt backbones emerged as the top-performing configuration, with ConvNeXtV1-T best for immunological synapse classification and ConvNeXtV2-T for morphological classification. We identify a clear pattern in transfer dynamics: ImageNet initialization benefits morphological classification, consistent with its visual similarity to natural images, whereas random initialization better captures the more domain-specific immunological synapse classification. SSL elevates class-specific F1-scores by over 35 percentage points for structurally complex classes at 1% of annotated data. We synthesize these insights into a unified set of guidelines for deploying self-supervised workflows in high-throughput IFC, and release the benchmark as a resource for future work.

0.27

Towards Scalable Context-Aware Single-Cell Spatial Transcriptomics Prediction from Histology Images

cs.CV ·2026-09-29 ·Zijun Gao, Chunbin Gu, Jinxi Xiang, Xiangde Luo, Pheng-Ann Heng
top venue similarity 0.66
Abstract · Accepted to NeurIPS 2026

Predicting gene expression from H&E-stained histology images offers a scalable alternative to costly spatial transcriptomics, yet most existing methods operate at the spot level, where signals from multiple cells are aggregated and critical cellular heterogeneity is obscured. Extending this paradigm to single-cell resolution is non-trivial. Naively applying pathology foundation models faces a scale mismatch: their patch-level representations mix multiple cells, whereas per-cell cropping or resizing distorts morphology and removes local context. Conversely, segmentation-based models without strong pretrained visual encoders often lack the morphological representation capacity needed for accurate molecular prediction and inherit errors from imperfect cell boundary masks. Here, we present CELLO, an efficient end-to-end framework that performs a single pathology foundation model forward pass per image and uses grid sampling to extract location-specific features for all cells simultaneously. We further introduce a distance-decay cross-attention module that refines each cell representation using spatially biased local morphological context. Using 52 public Xenium-H&E pairs from HEST-1k that span 12 organs and approximately 10 million cells, CELLO improves the average predictive accuracy over the evaluated baselines while reducing the mean whole-slide inference time compared to DeepSpot2Cell, a 14.0x speed-up on average that excludes upstream cell segmentation. Our work establishes a scalable foundation for single-cell gene expression prediction from H&E images.

0.45

HEmIF-Bench: Benchmarking H&E-to-mIF Models BeyondVirtual-StainFidelity

cs.CV ·2026-11-15 ·Fuxian Zhao, Hyokeun Park
benchmark similarity 0.65
Abstract · 11 pages, 3 figures, 2 tables

Hematoxylin and eosin (H&E)-to-multiplex immunofluorescence (mIF) generators predict spatial protein expression from routine histology, yet pixel-level marker reconstruction does not establish downstream utility. We present HEmIF-Bench, evaluating five frozen generators across eight datasets spanning molecular, cellular, tissue, and patient scales. HEmIF-Bench decouples internal encoder features from generated outputs, benchmarking both against the pathology foundation reference UNI2. Mirroring the clinical workflow where pathologists rely on mIF to define cell phenotypes, delineate tertiary lymphoid structures (TLSs) and germinal centers (GCs), and stratify patient risk, we evaluate external CD3 recovery, single-cell classification, dense nuclear segmentation, TLS/GC segmentation, and patient survival prediction. Across the benchmark, foundation-model-based MIPHEI-ViT leads among the generators, while non-foundation models show task-specific strengths. Comparing the two routes reveals that internal encoder features generally outperform generated outputs, and larger output marker panels do not guarantee stronger downstream utility across datasets. Moreover, neither internal encoder features nor generated outputs consistently surpass frozen UNI2. These findings show that pixel-level stain fidelity does not equate to downstream utility, and that generators trained at current paired-data scales have yet to surpass large-scale pure-H&E foundation models. With the expansion of paired translation cohorts and the advancement of foundation-based generative architectures, HEmIF-Bench establishes a definitive benchmark for tracking when H&E-to-mIF generation crosses the threshold to deliver genuine value beyond routine histology for tumor microenvironment analysis and precision oncology.

0.13

Interpretable Multi-Instance Learning Enables Early Prediction of Key Molecular Alterations from Routine Flow Cytometry in Acute Myeloid Leukemia

cs.LG ·2026-09-16 ·Jonathan Legrand, Aguirre Mimoun, Baudouin Denis de Senneville, Audrey Bidet, Pierre-Yves Dumas +1 more
similarity 0.65
Abstract

Background: Molecular testing for NPM1 and FLT3-ITD mutations guides critical early treatment decisions in acute myeloid leukemia (AML), but results can take weeks, long after these decisions must be made. Flow cytometry, already performed within hours of admission as part of routine care, may carry enough signal to predict these mutations directly, without added cost or delay. Methods: We developed an interpretable multi-instance learning classifier based on a decision tree, in which each patient sample is modeled as a collection of individual cells and mutation status is inferred from cell-level predictions. The model was benchmarked against a random forest trained on clinical variables and a deep convolutional neural network adapted for multitube flow cytometry data. Performance was assessed by cross-validation on a discovery cohort of 197 patients and tested on an independent cohort of 161 patients, using the area under the receiver operating characteristic curve (AUROC) and positive predictive value. Results: In cross-validation on the discovery cohort, the MIL model achieved mean AUROCs of 0.96 (SD=0.05) for NPM1 and 0.86 (SD=0.10) for FLT3-ITD, outperforming the clinical baseline and matching deep learning approaches. The model then successfully generalized to the independent test cohort of 161 patients, reaching AUROCs of 0.90 (NPM1) and 0.82 (FLT3-ITD), with positive predictive values of 0.87 and 0.68, respectively. Cell-level interpretation recovered established immunophenotypic signatures (CD33${}^{+}$ /CD34___ for NPM1-mutated cases, CD33${}^{+}$ /low side-scatter for FLT3-ITD), directly linking model predictions to known biology. Conclusions: These results show that an interpretable model applied to data already collected in routine care can predict AML molecular status within hours, offering a practical route to earlier, biology-informed treatment decisions.

0.20